compounded semaglutide or tirzepatide Troubling Findings in Study of GLP-1 Compounders Semaglutide vs Tirzepatide: Which Is

Clinical studies have shown that participants using tirzepatide experienced significant reductions in body mass, with some achieving decreases of up to 22.5%

Ozempic is not recommended in patients with severe gastroparesis Hypersensitivity: Serious hypersensitivity reactions (e.g., anaphylaxis, angioedema) have been reported in patients treated with Ozempic

Biochem Biophys Res Commun 336: 1028-1032, 2005

This evidence, drawn from several major clinical trials, reveals that GLP-1 RAs like Semaglutide and Tirzepatide can significantly reduce the risk of cardiovascular events, chronic kidney disease, and liver disease while improving conditions like sleep apnea and osteoarthritis